新冠康复者的常见长期后遗症研究进展及健康管理对策建议

doi:10.12183/j.scjpm.2024.0191

摘要/Abstract

摘要： 新型冠状病毒感染（简称新冠感染）自2019年底暴发以来一直受到世界各国高度关注,严重影响了全球的公共卫生、经济和社会。有10%~30%的新冠感染患者康复后会发展为“长新冠”,对日常工作和生活产生诸多不良影响,实施及时全面的健康管理对于有效应对“长新冠”至关重要。本研究将对新冠康复者的常见长期后遗症进行系统综述,并结合国内外目前实施的健康管理实践经验进行总结,最终完善新冠感染患者康复后的健康管理策略,为策略制定提供借鉴。

关键词: “长新冠”综合征, 后遗症, 健康管理, 新型冠状病毒感染, 对策

中图分类号:

R183.3

薛建华, 徐德武, 单雪晴, 田建广, 冯爱成. 新冠康复者的常见长期后遗症研究进展及健康管理对策建议[J]. 华南预防医学, 2024, 50(2): 191-194.

XUE Jianhua, XU Dewu, SHAN Xueqing, et al. Research progress on common long-term sequelae of COVID-19 rehabilitation patients and corresponding measures for health management[J]. South China Journal of Preventive Medicine, 2024, 50(2): 191-194.

参考文献

[1] 王文媛,王舒颖,李万怡,等.“长新冠”临床表现研究进展[J].山东医药,2023,63(3):91-95.
[2] Yong SJ,Liu S.Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies[J].Rev Med Virol,2022,32(4):e2315.
[3] Woodby B,Arnold MM,Valacchi G.SARS-CoV-2 infection,COVID-19 pathogenesis,and exposure to air pollution: What is the connection?[J]. Ann N Y Acad Sci,2021,1486(1):15-38.
[4] Mostafa-Hedeab G,Al-Kuraishy HM,Al-Gareeb AI,et al. Selinexor and COVID-19: The neglected warden[J]. Front Pharmacol,2022,13:884228.
[5] van Kessel SAM,Olde Hartman TC,Lucassen PLBJ,et al. Post-acute and long-COVID-19 symptoms in patients with mild diseases: A systematic review[J]. Fam Pract,2022,39(1):159-167.
[6] Mandal S,Barnett J,Brill S E,et al.‘Long-COVID’: A cross-sectional study of persisting symptoms,biomarker and imaging abnormalities following hospitalisation for COVID-19[J]. Thorax,2021,76(4):396-398.
[7] Cobos-Siles M,Cubero-Morais P,Arroyo-Jimenez I,et al. Cause-specific death in hospitalized individuals infected with SARS-CoV-2: More than just acute respiratory failure or thromboembolic events[J]. Intern Emerg Med,2020,15(8):1533-1544.
[8] Goertz Y,Van Herck M,Delbressine JM,et al.Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome?[J]. ERJ Open Res,2020,6(4).00542-2020.
[9] Sonnweber T,Sahanic S,Pizzini A,et al.Cardiopulmonary recovery after COVID-19: An observational prospective multicentre trial[J].Eur Respir J,2021,57(4):2003481.
[10] Tanni SE,Fabro AT,de Albuquerque A,et al. Pulmonary fibrosis secondary to COVID-19: A narrative review[J]. Expert Rev Respir Med,2021,15(6):791-803.
[11] Evans PC,Rainger GE,Mason JC,et al.Endothelial dysfunction in COVID-19: A position paper of the ESC Working Group for Atherosclerosis and Vascular Biology,and the ESC Council of Basic Cardiovascular Science[J].Cardiovasc Res,2020,116(14):2177-2184.
[12] Yong SJ.Persistent brainstem dysfunction in Long-COVID: A hypothesis[J]. ACS Chem Neurosci,2021,12(4):573-580.
[13] Stefanou MI,Palaiodimou L,Bakola E,et al.Neurological manifestations of long-COVID syndrome: A narrative review[J]. Ther Adv Chronic Dis,2022,13:20406223221076890.
[14] Huang C,Huang L,Wang Y,et al.6-month consequences of COVID-19 in patients discharged from hospital: A cohort study[J].Lancet,2021,397(10270):220-232.
[15] Davis HE,Assaf GS,Mccorkell L,et al.Characterizing long COVID in an international cohort: 7 months of symptoms and their impact[J]. EClinicalMedicine,2021,38:101019.
[16] Lopez-Leon S,Wegman-Ostrosky T,Perelman C,et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis[J].Sci Rep,2021,11(1):16144.
[17] Tang SW,Helmeste D,Leonard B.Inflammatory neuropsychiatric disorders and COVID-19 neuroinflammation[J]. Acta Neuropsychiatr,2021,33(4):165-177.
[18] Kamal M,Abo Omirah M,Hussein A,et al.Assessment and characterisation of post-COVID-19 manifestations[J].Int J Clin Pract,2021,75(3):e13746.
[19] Rovere QP,De Lorenzo R,Conte C,et al.Post-COVID-19 follow-up clinic: Depicting chronicity of a new disease[J]. Acta Biomed,2020,91(9-S):22-28.
[20] Gasecka A,Pruc M,Kukula K,et al.Post-COVID-19 heart syndrome[J]. Cardiol J,2021,28(2):353-354.
[21] Onohuean H,Al-Kuraishy HM,Al-Gareeb AI,et al. Covid-19 and development of heart failure: Mystery and truth[J]. Naunyn Schmiedebergs Arch Pharmacol,2021,394(10):2013-2021.
[22] Puntmann VO,Carerj ML,Wieters I,et al.Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)[J]. JAMA Cardiol,2020,5(11):1265-1273.
[23] Rajpal S,Tong MS,Borchers J,et al.Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection[J]. JAMA Cardiol,2021,6(1):116-118.
[24] Steenblock C,Hassanein M,Khan EG,et al.Diabetes and COVID-19: Short- and long-term consequences[J]. Horm Metab Res,2022,54(8):503-509.
[25] Steenblock C,Schwarz P,Ludwig B,et al.COVID-19 and metabolic disease: Mechanisms and clinical management[J]. Lancet Diabetes Endocrinol,2021,9(11):786-798.
[26] Costa FF,Rosario WR,Ribeiro FA,et al.Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies[J]. Diabetes Metab Syndr,2020,14(5):809-814.
[27] Docherty AB,Harrison EM,Green CA,et al.Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Prospective observational cohort study[J]. BMJ,2020,369:m1985.
[28] Montefusco L,Ben NM,D'Addio F,et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection[J]. Nat Metab,2021,3(6):774-785.
[29] Barrett CE,Koyama AK,Alvarez P,et al.Risk for newly diagnosed diabetes >30 Days after SARS-CoV-2 infection among persons aged <18 years - United States,March 1,2020-June 28,2021[J].MMWR Morb Mortal Wkly Rep,2022,71(2):59-65.
[30] Birabaharan M,Kaelber DC,Pettus JH,et al.Risk of new-onset type 2 diabetes in 600 055 people after COVID-19: A cohort study[J]. Diabetes Obes Metab,2022,24(6):1176-1179.
[31] Al-Kuraishy HM,Al-Gareeb AI. Covid-19 and acute kidney injury: A new perspective[J]. J Pak Med Assoc,2021,71(Suppl 8)(12):S166-S169.
[32] Chioh FW,Fong SW,Young BE,et al.Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation[J]. Elife,2021,10:e64909.
[33] Weng J,Li Y,Li J,et al.Gastrointestinal sequelae 90 days after discharge for COVID-19[J]. Lancet Gastroenterol Hepatol,2021,6(5):344-346.
[34] Liska D,Liptakova E,Babicova A,et al.What is the quality of life in patients with long COVID compared to a healthy control group?[J].Front Public Health,2022,10:975992.
[35] COVID-19 rapid guideline: Managing the long-term effects of COVID-19[M]. London:National Institute for Health and Care Excellence (NICE),2020.
[36] Fisher D,Mak K.Exiting the pandemic: Singapore style[J].BMC Med,2021,19(1):238.
[37] Lippi G,Sanchis-Gomar F,Henry BM. COVID-19 and its long-term sequelae: What do we know in 2023?[J]. Pol Arch Intern Med,2023,133(4):16402.
[38] Taquet M,Dercon Q,Harrison PJ.Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections[J].Brain Behav Immun,2022,103:154-162.
[39] Storz MA.Lifestyle adjustments in Long-COVID management: Potential benefits of plant-based diets[J].Curr Nutr Rep,2021,10(4):352-363.
[40] Benavides H,Meireles CL,Benavente V,et al.Decreasing older adult COVID-19 risk factors using digital technology to implement a plant-based-diet: An opinion paper[J].JMIR Aging,2021,4(3):e25327.
[41] Ostfeld RJ.Definition of a plant-based diet and overview of this special issue[J].J Geriatr Cardiol,2017,14(5):315.
[42] Davin-Casalena B,Lutaud R,Scronias D,et al. French general practitioners frequently see patients with long-COVID[J]. J Am Board Fam Med,2021,34(5):1010-1013.
[43] 中华人民共和国国家卫生健康委员会.全力做好新型冠状病毒感染疫情防疫工作[EB/OL]. (2022-12-24)[2023-06-16].http://www.nhc.gov.cn/xcs/xxgzbd/gzbd_index.shtml.